Specialty pathology
Histopathology has evolved to be a key endpoint in the development of new and novel therapies.
Our world-leading specialty pathology team of dedicated scientists offer a range of drug development services including: immunohistochemistry, in-situ hybridization, electron microscopy and digital imaging and analysis, using state-of-the-art technologies and equipment.
All procedures are performed in compliance to the industry highest standard of GLP regulations.
In Situ Hybridization (ISH)
Evaluate nucleic acids in tissue sections using reproducible, automated techniques and choose from validated methods or leverage our expertise to develop a novel method. Multiplex methods allow for simultaneous evaluation of proteins and nucleic acids in a single section.
Tissue Profiling
Banks of high quality research models and human tissues, xenografts and cell lines are available for assay development and for use as controls when naïve or specialty tissues are needed.
Stand-Alone Services
We can receive samples from studies conducted elsewhere and are able to perform any histology or specialty service, with or without pathologist interpretation on those studies. Certain specialty pathology sites can also receive human tissue for analysis.
Exploratory Clinical Biomarkers
Immunohistochemistry is an important tool for evaluating proteins in tissue sections from clinical trial patients that may be prognostic, or predictive of treatment for diseases such as cancer.